Protease activated receptor‐1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood–brain barrier

Publisher： John Wiley & Sons Inc

E-ISSN： 1471-4159|135|3|577-588

ISSN： 0022-3042

Source： JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.135, Iss.3, 2015-11, pp. : 577-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The blood–brain barrier internalises Cryptococcus neoformans via the EphA2‐tyrosine kinase receptor

By  

CELLULAR MICROBIOLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type 1 diabetes exacerbates blood–brain barrier alterations during experimental epileptic seizures in an animal model

By  

CELL BIOCHEMISTRY AND FUNCTION (ELECTRONIC), Vol. 33, Iss. 5, 2015-07 ,pp. : 285-292

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator‐activated receptor alpha (Pparα) at the blood–brain barrier

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 135, Iss. 6, 2015-12 ,pp. : 1113-1122

John Wiley & Sons Inc

Access to resources Recommend Favorite

The dynamic blood–brain barrier

By  

FEBS JOURNAL (ELECTRONIC), Vol. 282, Iss. 21, 2015-11 ,pp. : 4067-4079

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blockage of protease‐activated receptor 1 ameliorates heat‐stress induced intestinal high permeability and bacterial translocation

By  

CELL BIOLOGY INTERNATIONAL, Vol. 39, Iss. 4, 2015-04 ,pp. : 411-417

John Wiley & Sons Inc

Access to resources Recommend Favorite